273 related articles for article (PubMed ID: 24902640)
21. Attitudes and Parameters Affecting the Behavior Toward Precursor Symptoms of Head and Neck Cancer.
Vlastarakos PV; Gkouvali A; Katsochi D
Ear Nose Throat J; 2019 Jul; 98(6):E58-E63. PubMed ID: 31018688
[TBL] [Abstract][Full Text] [Related]
22. Risk factor profiles of head and neck cancer patients of Andhra Pradesh, India.
Addala L; Pentapati CK; Reddy Thavanati PK; Anjaneyulu V; Sadhnani MD
Indian J Cancer; 2012; 49(2):215-9. PubMed ID: 23107973
[TBL] [Abstract][Full Text] [Related]
23. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers.
Gillison ML; D'Souza G; Westra W; Sugar E; Xiao W; Begum S; Viscidi R
J Natl Cancer Inst; 2008 Mar; 100(6):407-20. PubMed ID: 18334711
[TBL] [Abstract][Full Text] [Related]
24. Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer.
Jain KS; Sikora AG; Baxi SS; Morris LG
Cancer; 2013 May; 119(10):1832-7. PubMed ID: 23423883
[TBL] [Abstract][Full Text] [Related]
25. Awareness of head and neck cancers in Saudi Arabia. A questionnaire based study.
Alqaryan S; Aldrees T; Almatrafi S; Alharbi A; Alhumaid H
Saudi Med J; 2020 Apr; 41(4):400-405. PubMed ID: 32291427
[TBL] [Abstract][Full Text] [Related]
26. Is use of the human papillomavirus vaccine among female college students related to human papillomavirus knowledge and risk perception?
Licht AS; Murphy JM; Hyland AJ; Fix BV; Hawk LW; Mahoney MC
Sex Transm Infect; 2010 Feb; 86(1):74-8. PubMed ID: 19841004
[TBL] [Abstract][Full Text] [Related]
27. Association between p53 and human papillomavirus in head and neck cancer survival.
Smith EM; Wang D; Rubenstein LM; Morris WA; Turek LP; Haugen TH
Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):421-7. PubMed ID: 18268127
[TBL] [Abstract][Full Text] [Related]
28. Awareness and knowledge of human papillomavirus in the Swedish adult population.
Dahlström LA; Sundström K; Young C; Lundholm C; Sparén P; Tran TN
J Adolesc Health; 2012 Feb; 50(2):204-6. PubMed ID: 22265119
[TBL] [Abstract][Full Text] [Related]
29. Refining the head and neck cancer referral guidelines: a two-centre analysis of 4715 referrals.
Tikka T; Pracy P; Paleri V
Clin Otolaryngol; 2016 Feb; 41(1):66-75. PubMed ID: 26611658
[TBL] [Abstract][Full Text] [Related]
30. Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival.
Haraf DJ; Nodzenski E; Brachman D; Mick R; Montag A; Graves D; Vokes EE; Weichselbaum RR
Clin Cancer Res; 1996 Apr; 2(4):755-62. PubMed ID: 9816227
[TBL] [Abstract][Full Text] [Related]
31. National prevalence of oral HPV infection and related risk factors in the U.S. adult population.
Sanders AE; Slade GD; Patton LL
Oral Dis; 2012 Jul; 18(5):430-41. PubMed ID: 22251072
[TBL] [Abstract][Full Text] [Related]
32. Gaps in public knowledge of peripheral arterial disease: the first national PAD public awareness survey.
Hirsch AT; Murphy TP; Lovell MB; Twillman G; Treat-Jacobson D; Harwood EM; Mohler ER; Creager MA; Hobson RW; Robertson RM; Howard WJ; Schroeder P; Criqui MH;
Circulation; 2007 Oct; 116(18):2086-94. PubMed ID: 17875966
[TBL] [Abstract][Full Text] [Related]
33. Educational Value of a Medical Student-Led Head and Neck Cancer Screening Event.
Freiser ME; Desai DD; Azcarate PM; Szczupak M; Cohen ER; Raffa FN; George JS; Lo K; Nayak CS; Weed DT; Sargi ZB
Otolaryngol Head Neck Surg; 2016 Apr; 154(4):638-44. PubMed ID: 26786264
[TBL] [Abstract][Full Text] [Related]
34. Years of potential life lost and productivity costs because of cancer mortality and for specific cancer sites where human papillomavirus may be a risk factor for carcinogenesis-United States, 2003.
Ekwueme DU; Chesson HW; Zhang KB; Balamurugan A
Cancer; 2008 Nov; 113(10 Suppl):2936-45. PubMed ID: 18980277
[TBL] [Abstract][Full Text] [Related]
35. Awareness and Knowledge of Emergent Ophthalmic Disease Among Patients in an Internal Medicine Clinic.
Uhr JH; Mishra K; Wei C; Wu AY
JAMA Ophthalmol; 2016 Apr; 134(4):424-31. PubMed ID: 26892039
[TBL] [Abstract][Full Text] [Related]
36. The Burden of Head and Neck Cancer in the United States, 1990 - 2017.
Ludwig DC; Morrison SD; Dillon JK
J Oral Maxillofac Surg; 2021 Oct; 79(10):2162-2170. PubMed ID: 34153257
[TBL] [Abstract][Full Text] [Related]
37. Temporal nodal regression and regional control after primary radiation therapy for N2-N3 head-and-neck cancer stratified by HPV status.
Huang SH; O'Sullivan B; Xu W; Zhao H; Chen DD; Ringash J; Hope A; Razak A; Gilbert R; Irish J; Kim J; Dawson LA; Bayley A; Cho BC; Goldstein D; Gullane P; Yu E; Perez-Ordonez B; Weinreb I; Waldron J
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1078-85. PubMed ID: 24210079
[TBL] [Abstract][Full Text] [Related]
38. [Papillomavirus and head and neck cancer].
Lescaille G; Descroix V; Azérad J
Rev Stomatol Chir Maxillofac; 2011 Jun; 112(3):160-3. PubMed ID: 21596407
[TBL] [Abstract][Full Text] [Related]
39. Controversies surrounding human papilloma virus infection, head & neck vs oral cancer, implications for prophylaxis and treatment.
Campisi G; Giovannelli L
Head Neck Oncol; 2009 Mar; 1():8. PubMed ID: 19331691
[TBL] [Abstract][Full Text] [Related]
40. Targeting Head and Neck Cancer by Vaccination.
Wang C; Dickie J; Sutavani RV; Pointer C; Thomas GJ; Savelyeva N
Front Immunol; 2018; 9():830. PubMed ID: 29740440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
